| Pharmaceutical Information |
| Drug Name |
Secobarbital sodium |
| Drug ID |
BADD_D01998 |
| Description |
Secobarbital (marketed by Eli Lilly and Company under the brand names Seconal and Tuinal) is a barbiturate derivative drug with anaesthetic, anticonvulsant, sedative and hypnotic properties. It is commonly known as quinalbarbitone in the United Kingdom. |
| Indications and Usage |
For the Short-term treatment of intractable insomnia for patients habituated to barbiturates |
| Marketing Status |
approved; vet_approved |
| ATC Code |
N05CA06 |
| DrugBank ID |
DB00418
|
| KEGG ID |
D01310
|
| MeSH ID |
D012631
|
| PubChem ID |
14148199
|
| TTD Drug ID |
D00SJE
|
| NDC Product Code |
0792-0128 |
| UNII |
XBP604F6UM
|
| Synonyms |
Secobarbital | Meballymal | Quinalbarbitone | Sebar | Seconal Sodium | Seconal | Secobarbital Sodium | Sodium, Secobarbital |
|
| Chemical Information |
| Molecular Formula |
C12H17N2NaO3 |
| CAS Registry Number |
309-43-3 |
| SMILES |
CCCC(C)C1(C(=O)NC(=O)[N-]C1=O)CC=C.[Na+] |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
